WHO ICTRP trial
Colchicine in patients with myocardial infarction
IRCT20210423051047N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20210423051047N2 |
|---|---|
| Public title | Colchicine in patients with myocardial infarction |
| Scientific title | Anti-inflammatory effect of cholchicine in acute coronary syndrome |
| Primary sponsor | Iran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Acute myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction |
| Interventions | Intervention 1: Intervention group: Patients receive 1 mg colchicine tablet made by Modava Pharmaceutical Company as 1 mg at first and 1 mg one hour after Primary PCI. Intervention 2: Control group: Patients receive colchicine placebo made… |
| Registration date | Sep 10, 2021 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: